Back to results
US 2006/0141024 A1Published application
Synergistic combination kit of alpha,beta-arteether, sulfadoxin and pyrimethamine for treatment of severe/multi-drug resistant cerebral malaria
AssigneeCouncil of Sientific and Industrial Research
InventorsRenu Tripathi, Sunil Puri, Jagdishwar Srivastava, Satyawan Singh, Omkar Asthana, Anil Dwivedi
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for preparation of synergistic combination kits of α,β-arteether, sulfadoxin and pyrimethamine for the treatment of severe/multi-drug resistant cerebral malaria.
Claims13
A combination kit for the treatment of malaria caused by P. falciparum for a period of two to five days schedule, the kit comprising:
- a. individual dose of anti-malarial agents sulfadoxine and pyrimethamine;
- and
- b. individual dose of anti-malarial agent α,β arteether;
- c. instruction manual for the administration of the three antimalarial drugs.
1 more element
A method for the treatment of malaria caused by P. falciparum comprising administering to a subject malarial medication contained in a combination kit which in turn comprises:
- a. individual dose of anti-malarial agents sulfadoxine and pyrimethamnine and
- b. individual dose of anti-malarial agent α,β arteether;
- c. instruction manual for the administration of the three antimalarial drugs.
Dependencies are inferred from the claim text.